| Title : Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice - Ervinna_2013_Endocrinology_154_1260 |
| Author(s) : Ervinna N , Mita T , Yasunari E , Azuma K , Tanaka R , Fujimura S , Sukmawati D , Nomiyama T , Kanazawa A , Kawamori R , Fujitani Y , Watada H |
| Ref : Endocrinology , 154 :1260 , 2013 |
| Abstract : Ervinna_2013_Endocrinology_154_1260 |
| ESTHER : Ervinna_2013_Endocrinology_154_1260 |
| PubMedSearch : Ervinna_2013_Endocrinology_154_1260 |
| PubMedID: 23337530 |
| Title : Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor linagliptin: a 4-week multicenter, randomized, double-blind, placebo-controlled phase IIa study in Japanese type 2 diabetes patients - Horie_2011_Clin.Ther_33_973 |
| Author(s) : Horie Y , Kanada S , Watada H , Sarashina A , Taniguchi A , Hayashi N , Graefe-Mody EU , Woerle HJ , Dugi KA |
| Ref : Clin Ther , 33 :973 , 2011 |
| Abstract : Horie_2011_Clin.Ther_33_973 |
| ESTHER : Horie_2011_Clin.Ther_33_973 |
| PubMedSearch : Horie_2011_Clin.Ther_33_973 |
| PubMedID: 21723606 |